Primary Hyperparathyroidism: Effects on Bone Health

Area of Science:

• Endocrinology
• Nephrology
• Bone Metabolism

Background:

• Primary hyperparathyroidism (PHPT) is the leading cause of chronic hypercalcemia.
• Routine calcium screening has shifted PHPT presentation towards milder, asymptomatic disease.
• Elevated or inappropriately normal serum parathyroid hormone levels characterize PHPT-induced hypercalcemia.

Purpose of the Study:

• To review the epidemiology, clinical presentation, and management of PHPT.
• To highlight the diagnostic criteria and current sequelae of PHPT.
• To emphasize the efficacy of parathyroidectomy as the definitive treatment.

Main Methods:

• Literature review of PHPT diagnosis and treatment.
• Analysis of common causes including single-gland adenoma, hyperplasia, and carcinoma.
• Evaluation of clinical sequelae such as diminished bone mineral density and nephrolithiasis.

Main Results:

• Single-gland adenoma accounts for 80% of PHPT cases.
• Diminished bone mineral density and kidney stones are significant clinical outcomes.
• Parathyroidectomy achieves approximately 98% cure rates when performed by experienced surgeons.

Conclusions:

• PHPT is a prevalent endocrine disorder often detected through screening.
• Parathyroidectomy remains the gold standard for PHPT treatment, offering high success rates.
• Early diagnosis and intervention can mitigate long-term complications like bone loss and kidney stones.